Impact of type 2 diabetes and the metabolic syndrome on myocardial structure and microvasculature of men with coronary artery disease

Cardiovascular Diabetology

Volumn 10, Issue , 2011, Pages

  Campbell, Duncan J ^a,b   Somaratne, Jithendra B ^c   Jenkins, Alicia J ^b   Prior, David L ^a,b,c   Yii, Michael ^b,c   Kenny, James F ^c   Newcomb, Andrew E ^b,c   Schalkwijk, Casper G ^d   Black, Mary J ^e   Kelly, Darren J ^b  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c University of Maastricht ^*  (Australia)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e MONASH UNIVERSITY   (Australia)

Author keywords

Advanced glycation end products; Capillary length density; Diabetic cardiomyopathy; Fibrosis; Metabolic syndrome; Type 2 diabetes

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; FIBROSING ALVEOLITIS; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART MUSCLE; HEART MUSCLE BIOPSY; HUMAN; HUMAN TISSUE; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; MICROVASCULATURE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN EXPRESSION; COMPARATIVE STUDY; LUNG WEDGE PRESSURE; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGED; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; HUMANS; MALE; METABOLIC SYNDROME X; MICROVESSELS; MIDDLE AGED; MYOCARDIUM; PULMONARY WEDGE PRESSURE;

EID: 80052851550     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-10-80     Document Type: Article

References (48)

1. Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 2004, 25:543-567. 10.1210/er.2003-0012, 15294881.
2. Horwich TB, Fonarow GC. Glucose, obesity, metabolic syndrome, and diabetes relevance to incidence of heart failure. J Am Coll Cardiol 2010, 55:283-293. 10.1016/j.jacc.2009.07.029, 2834416, 20117431.
3. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 1972, 30:595-602. 10.1016/0002-9149(72)90595-4, 4263660.
4. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 1974, 34:29-34. 10.1016/0002-9149(74)90089-7, 4835750.
5. Poornima IG, Parikh P, Shannon RP. Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ Res 2006, 98:596-605. 10.1161/01.RES.0000207406.94146.c2, 16543510.
6. Lewis EF, Solomon SD, Jablonski KA, Rice MM, Clemenza F, Hsia J, Maggioni AP, Zabalgoitia M, Huynh T, Cuddy TE, Gersh BJ, Rouleau J, Braunwald E, Pfeffer MA. Predictors of heart failure in patients with stable coronary artery disease: a PEACE study. Circ Heart Fail 2009, 2:209-216. 10.1161/CIRCHEARTFAILURE.108.820696, 3009573, 19808342.
7. Candido R, Forbes JM, Thomas MC, Thallas V, Dean RG, Burns WC, Tikellis C, Ritchie RH, Twigg SM, Cooper ME, Burrell LM. A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes. Circ Res 2003, 92:785-792. 10.1161/01.RES.0000065620.39919.20, 12623881.
8. Hsueh W, Abel ED, Breslow JL, Maeda N, Davis RC, Fisher EA, Dansky H, McClain DA, McIndoe R, Wassef MK, Rabadan-Diehl C, Goldberg IJ. Recipes for creating animal models of diabetic cardiovascular disease. Circ Res 2007, 100:1415-1427. 10.1161/01.RES.0000266449.37396.1f, 17525381.
9. Connelly KA, Kelly DJ, Zhang Y, Prior DL, Advani A, Cox AJ, Thai K, Krum H, Gilbert RE. Inhibition of protein kinase C-beta by ruboxistaurin preserves cardiac function and reduces extracellular matrix production in diabetic cardiomyopathy. Circ Heart Fail 2009, 2:129-137. 10.1161/CIRCHEARTFAILURE.108.765750, 19808328.
10. Hayashi T, Sohmiya K, Ukimura A, Endoh S, Mori T, Shimomura H, Okabe M, Terasaki F, Kitaura Y. Angiotensin II receptor blockade prevents microangiopathy and preserves diastolic function in the diabetic rat heart. Heart 2003, 89:1236-1242. 10.1136/heart.89.10.1236, 1767873, 12975429.
11. Gross ML, Heiss N, Weckbach M, Hansen A, El-Shakmak A, Szabo A, Munter K, Ritz E, Amann K. ACE-inhibition is superior to endothelin A receptor blockade in preventing abnormal capillary supply and fibrosis of the heart in experimental diabetes. Diabetologia 2004, 47:316-324. 10.1007/s00125-003-1309-z, 14727024.
12. Fein FS, Sonnenblick EH. Diabetic cardiomyopathy. Prog Cardiovasc Dis 1985, 27:255-270. 10.1016/0033-0620(85)90009-X, 3880919.
13. Nunoda S, Genda A, Sugihara N, Nakayama A, Mizuno S, Takeda R. Quantitative approach to the histopathology of the biopsied right ventricular myocardium in patients with diabetes mellitus. Heart Vessels 1985, 1:43-47. 10.1007/BF02066486, 4093355.
14. Shimizu M, Umeda K, Sugihara N, Yoshio H, Ino H, Takeda R, Okada Y, Nakanishi I. Collagen remodelling in myocardia of patients with diabetes. J Clin Pathol 1993, 46:32-36. 10.1136/jcp.46.1.32, 501107, 7679418.
15. Kawaguchi M, Techigawara M, Ishihata T, Asakura T, Saito F, Maehara K, Maruyama Y. A comparison of ultrastructural changes on endomyocardial biopsy specimens obtained from patients with diabetes mellitus with and without hypertension. Heart Vessels 1997, 12:267-274. 10.1007/BF02766802, 9860193.
16. van Hoeven KH, Factor SM. A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease. Circulation 1990, 82:848-855. 10.1161/01.CIR.82.3.848, 2394006.
17. Fischer VW, Barner HB, Leskiw ML. Capillary basal laminar thichness in diabetic human myocardium. Diabetes 1979, 28:713-719. 10.2337/diabetes.28.8.713, 446928.
18. Factor SM, Minase T, Sonnenblick EH. Clinical and morphological features of human hypertensive-diabetic cardiomyopathy. Am Heart J 1980, 99:446-458. 10.1016/0002-8703(80)90379-8, 6444776.
19. Kuethe F, Sigusch HH, Bornstein SR, Hilbig K, Kamvissi V, Figulla HR. Apoptosis in patients with dilated cardiomyopathy and diabetes: a feature of diabetic cardiomyopathy?. Horm Metab Res 2007, 39:672-676. 10.1055/s-2007-985823, 17846975.
20. Sunni S, Bishop SP, Kent SP, Geer JC. Diabetic cardiomyopathy. A morphological study of intramyocardial arteries. Arch Pathol Lab Med 1986, 110:375-381.
21. Frustaci A, Kajstura J, Chimenti C, Jakoniuk I, Leri A, Maseri A, Nadal-Ginard B, Anversa P. Myocardial cell death in human diabetes. Circ Res 2000, 87:1123-1132.
22. van Heerebeek L, Hamdani N, Handoko ML, Falcao-Pires I, Musters RJ, Kupreishvili K, Ijsselmuiden AJ, Schalkwijk CG, Bronzwaer JG, Diamant M, Borbely A, van der Velden J, Stienen GJ, Laarman GJ, Niessen HW, Paulus WJ. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation 2008, 117:43-51. 10.1161/CIRCULATIONAHA.107.728550, 18071071.
23. Sutherland CG, Fisher BM, Frier BM, Dargie HJ, More IA, Lindop GB. Endomyocardial biopsy pathology in insulin-dependent diabetic patients with abnormal ventricular function. Histopathology 1989, 14:593-602. 10.1111/j.1365-2559.1989.tb02200.x, 2759556.
24. Campbell DJ, Somaratne JB, Jenkins AJ, Prior DL, Yii M, Kenny JF, Newcomb AE, Kelly DJ, Black MJ. Differences in myocardial structure and coronary microvasculature between men and women with coronary artery disease. Hypertension 2011, 57:186-192. 10.1161/HYPERTENSIONAHA.110.165043, 21135353.
25. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006, 23:469-480. 10.1111/j.1464-5491.2006.01858.x, 16681555.
26. Zhu S, Heshka S, Wang Z, Shen W, Allison DB, Ross R, Heymsfield SB. Combination of BMI and Waist Circumference for Identifying Cardiovascular Risk Factors in Whites. Obes Res 2004, 12:633-645. 10.1038/oby.2004.73, 15090631.
27. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003, 26(Suppl 1):S5-S20. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.
28. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461-470.
29. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004, 27:1487-1495. 10.2337/diacare.27.6.1487, 15161807.
30. Januszewski AS, Thomas MC, Chung SJ, Karschimkus CS, Rowley KG, Nelson C, O'Neal D, Wang Z, Best JD, Jenkins AJ. Plasma low-molecular weight fluorescence in type 1 diabetes mellitus. Ann NY Acad Sci 2005, 1043:655-661. 10.1196/annals.1333.074, 16037289.
31. Tomita H, Egashira K, Ohara Y, Takemoto M, Koyanagi M, Katoh M, Yamamoto H, Tamaki K, Shimokawa H, Takeshita A. Early induction of transforming growth factor-β via angiotensin II type 1 receptors contributes to cardiac fibrosis induced by long-term blockade of nitric oxide synthesis in rats. Hypertension 1998, 32:273-279.
32. Gordon H, Sweets HH. A simple method for the silver impregnation of reticulin. Am J Pathol 1936, 12:545-552. 1911089, 19970284.
33. Schalkwijk CG, Baidoshvili A, Stehouwer CD, van Hinsbergh VW, Niessen HW. Increased accumulation of the glycoxidation product Nε-(carboxymethyl)lysine in hearts of diabetic patients: generation and characterisation of a monoclonal anti-CML antibody. Biochim Biophys Acta 2004, 1636:82-89.
34. Page A, Dumesnil JG, Clavel MA, Chan KL, Teo KK, Tam JW, Mathieu P, Despres JP, Pibarot P. Metabolic syndrome is associated with more pronounced impairment of left ventricle geometry and function in patients with calcific aortic stenosis: a substudy of the ASTRONOMER (Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin). J Am Coll Cardiol 2010, 55:1867-1874. 10.1016/j.jacc.2009.11.083, 20413039.
35. Rijzewijk LJ, van der Meer RW, Smit JW, Diamant M, Bax JJ, Hammer S, Romijn JA, de Roos A, Lamb HJ. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol 2008, 52:1793-1799. 10.1016/j.jacc.2008.07.062, 19022158.
36. Ilercil A, Devereux RB, Roman MJ, Paranicas M, O'Grady MJ, Lee ET, Welty TK, Fabsitz RR, Howard BV. Associations of insulin levels with left ventricular structure and function in American Indians: the strong heart study. Diabetes 2002, 51:1543-1547. 10.2337/diabetes.51.5.1543, 11978654.
37. Schofield I, Malik R, Izzard A, Austin C, Heagerty A. Vascular structural and functional changes in type 2 diabetes mellitus: evidence for the roles of abnormal myogenic responsiveness and dyslipidemia. Circulation 2002, 106:3037-3043. 10.1161/01.CIR.0000041432.80615.A5, 12473548.
38. Scognamiglio R, Negut C, De Kreutzenberg SV, Tiengo A, Avogaro A. Postprandial myocardial perfusion in healthy subjects and in type 2 diabetic patients. Circulation 2005, 112:179-184. 10.1161/CIRCULATIONAHA.104.495127, 15998667.
39. Rijzewijk LJ, van der Meer RW, Lamb HJ, de Jong HW, Lubberink M, Romijn JA, Bax JJ, de Roos A, Twisk JW, Heine RJ, Lammertsma AA, Smit JW, Diamant M. Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging. J Am Coll Cardiol 2009, 54:1524-1532. 10.1016/j.jacc.2009.04.074, 19815124.
40. Ritthaler U, Deng Y, Zhang Y, Greten J, Abel M, Sido B, Allenberg J, Otto G, Roth H, Bierhaus A, et al. Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease. Am J Pathol 1995, 146:688-694. 1869189, 7887450.
41. Barlovic DP, Soro-Paavonen A, Jandeleit-Dahm KA. RAGE biology, atherosclerosis and diabetes. Clin Sci (Lond) 2011, 121:43-55.
42. Campbell DJ, Kladis A, Zhang Y, Jenkins AJ, Prior DL, Yii M, Kenny JF, Black MJ, Kelly DJ. Increased tissue kallikrein levels in type 2 diabetes. Diabetologia 2010, 53:779-785. 10.1007/s00125-009-1645-8, 20225398.
43. Diamant M, Lamb HJ, Groeneveld Y, Endert EL, Smit JW, Bax JJ, Romijn JA, de Roos A, Radder JK. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol 2003, 42:328-335. 10.1016/S0735-1097(03)00625-9, 12875772.
44. Schrauwen-Hinderling VB, Kooi ME, Hesselink MK, Jeneson JA, Backes WH, van Echteld CJ, van Engelshoven JM, Mensink M, Schrauwen P. Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects. Diabetologia 2007, 50:113-120.
45. Zeina AR, Odeh M, Rosenschein U, Zaid G, Barmeir E. Coronary artery disease among asymptomatic diabetic and nondiabetic patients undergoing coronary computed tomography angiography. Coron Artery Dis 2008, 19:37-41. 10.1097/MCA.0b013e3282f2f19e, 18281814.
46. Rivera JJ, Nasir K, Choi EK, Yoon YE, Chun EJ, Choi SI, Choi DJ, Brancati FL, Blumenthal RS, Chang HJ. Detection of occult coronary artery disease in asymptomatic individuals with diabetes mellitus using non-invasive cardiac angiography. Atherosclerosis 2009, 203:442-448. 10.1016/j.atherosclerosis.2008.07.030, 18822414.
47. van den Brom CE, Bosmans JW, Vlasblom R, Handoko LM, Huisman MC, Lubberink M, Molthoff CF, Lammertsma AA, Ouwens MD, Diamant M, Boer C. Diabetic cardiomyopathy in Zucker diabetic fatty rats: the forgotten right ventricle. Cardiovasc Diabetol 2010, 9:25. 10.1186/1475-2840-9-25, 2898761, 20550678.
48. Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985, 5:587-592. 10.1016/S0735-1097(85)80380-6, 3156171.